Navigation Links
Immucor to Present at Upcoming Investor Conferences
Date:9/8/2009

NORCROSS, Ga., Sept. 8 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will webcast its presentations at two upcoming investor conferences.

Immucor will present at the Robert W. Baird & Co. 2009 Healthcare Conference in New York, NY on Thursday, September 10, 2009 at 12:15 pm Eastern Time. Immucor will also present at the UBS Global Life Sciences Conference in New York, NY on Tuesday, September 22, 2009 at 10:30 am Eastern Time.

Both presentations will be available via a live, simultaneous webcast. Access to the presentations will be available through the "About Us - Investor Information" section at www.immucor.com. For those unable to listen to the live broadcast, a replay of the presentation will be available shortly after its completion and will be archived on Immucor's website for approximately 60 days.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Immucor Announces Fiscal Fourth Quarter Results
2. Immucor Appoints Chief Operating Officer
3. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
4. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
5. Immucor Announces Fiscal Year 2010 Guidance
6. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
7. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
8. Immucor Receives Subpoena From Department of Justice
9. Immucor Announces Fiscal Third Quarter Results
10. Immucor Announces New Vice President, Operations
11. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery Institute ... pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, ... , Dr. Olson says the decision to support the pageant in an official ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: